Pioglitazone enhances splanchnic glucose uptake as well as peripheral glucose uptake in non-insulin-dependent diabetes mellitus

Diabetes Research and Clinical Practice

Volumn 41, Issue 1, 1998, Pages 35-43

  Kawamori, Ryuzo ^a   Matsuhisa, Munehide ^b   Kinoshita, Junichiro ^a   Mochizuki, Kentaro ^a   Niwa, Masataka ^a   Arisaka, Tomoyuki ^a   Ikeda, Masahiko ^b   Kubota, Minoru ^b   Wada, Masahiko ^c   Kanda, Tsutomu ^c   Ikebuchi, Motoyoshi ^d   Tohdo, Ryohei ^d   Yamasaki, Yoshimitsu ^b  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d Osaka Hospital   (Japan)

Author keywords

Glucose clamp; Insulin resistance; Muscle glucose uptake; Pioglitazone; Splanchnic glucose uptake

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; PIOGLITAZONE; PLACEBO; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; EDEMA; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TRANSPORT; GOOD CLINICAL PRACTICE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; ORAL GLUCOSE TOLERANCE TEST; PARESTHESIA; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RETINOPATHY; SPLANCHNIC BLOOD FLOW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MALE; MIDDLE AGED; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0031873331     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8227(98)00056-4     Document Type: Article

References (26)

1. Eriksson J., Franssila-Kallunki A., Ekstrand A. et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. New Engl. J. Med. 321:1989;337-343.
2. Efendic S., O'Stenson C.G. Hormonal responses and future treatment of non-insulin-dependent diabetes mellitus (NIDDM). J. Intern. Med. 234:1993;127-138.
3. Sugiyama Y., Taketomi S., Shimura Y., Ikeda H., Fujita T. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats. Arzneim-Forsch. Drug Res. 40:1990;263-267.
4. Ikeda H., Taketomi S., Sugiyama Y. et al. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Arzneim-Forsch. Drug Res. 40:1990;156-162.
5. Sugiyama Y., Shimura Y., Ikeda H. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats. Arzneim-Forsch. Drug Res. 40:1990;436-440.
6. DeFronzo R.A., Tobin J.D., Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 273:1979;E214-223.
7. DeFronzo R.A., Jacot E., Jequier E., Maeder E., Wahren J., Felber J.P. The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 30:1981;1000-1007.
8. Kawamori R., Morishima T., Ikeda M. et al. Effect of strict metabolic control on glucose handling by the liver and peripheral tissues in non-insulin-dependent diabetes mellitus. Diabetes Res. Clin. Pract. 23:1994;155-161.
9. Shichiri M., Kawamori R., Yamasaki Y., Kamada T. Clinical applications of a bedside-type artificial endocrine pancreas-development and application of the control algorithm. Artif. Organs Today. 1:1991;13-22.
10. DeFronzo R.A., Gunnarsson R., Bjorkman O., Olsson M., Warren J. Effects of insulin on peripheral and splanchnic glucose metabolism in non-insulin-dependent (type II) diabetes mellitus. J. Clin. Invest. 76:1985;149-155.
11. DeFronzo R.A., Ferrannini E., Hendler R., Wahren J., Felig P. Influence of hyperinsulinemia, hyperglycemia and the route of glucose administration on splanchnic glucose exchange. Proc. Natl. Acad. Sci. USA. 75:1978;5173-5177.
12. Ferrannini E., Wahren J., Feling P., DeFronzo R.A. The role of fractional glucose extraction in the regulation of splanchnic glucose metabolism in normal and diabetic man. Metabolism. 29:1980;28-35.
13. Waldhäusl W., Bratusch-Marrain P., Gasic S., Korn A., Nowotny P. Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia. 17:1979;221-227.
14. Kuyumjian J., Kalant N. Absorption of an oral dog glucose load in the dog. Horm. Metab. Res. 18:1986;578-589.
15. Gulliford M.C., Bicknell E.J., Pover G.G., Scarpello J.H. Intestinal glucose and amino acid absorption in healthy volunteers and non-insulin-dependent diabetic subjects. Am. J. Clin. Nutr. 49:1989;1247-1251.
16. Revers R.R., Fink R., Griffin J., Olefsky J.M., Kolterman O.G. Influence of hyperglycemia on insulin's in vivo effect in type II diabetes. J. Clin. Invest. 73:1984;664-672.
17. Garvery W.T., Olefsky J.M., Griffin J., Hamman R.F., Kolterman O.G. The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus. Diabetes. 34:1985;222-234.
18. Matsuhisa M., Shi Z.Q., Calvin W. et al. The effect of pioglitazone on hepatic glucose uptake measured with indirect and direct methods in alloxan-induced diabetic dog. Diabetes. 46:1997;224-231.
19. Kingston W.J., Livingston J.N., Moxiey R.T. Enhancement of insulin action after oral glucose ingestion. J. Clin. Invest. 77:1986;1153-1162.
20. Ludvik B., Nolan J., Roberts A. et al. A non-invasive method to measure splanchnic glucose uptake after oral glucose administration. J. Clin. Invest. 95:1995;2232-2238.
21. Andrews W.J., Vasquez B., Nagulesparan M. et al. Insulin therapy in obese non-insulin dependent diabetes induces improvements in insulin action and secretion that are maintained for two weeks after insulin withdrawal. Diabetes. 33:1984;634-642.
22. Scarlett J.A., Gray R.S., Griffin J., Olefsky J.M., Kolterman O.G. Insulin treatment reverses the insulin resistance of type II diabetes mellitus. Diabetes Care. 5:1982;353-363.
23. Kobayashi M., Iwanishi M., Egawa K., Shigeta Y. Pioglitazone increases insulin sensitivity by activating insulin receptor kinase. Diabetes. 41:1992;476-483.
24. Maegawa H., Tachikawa-Ide R., Ugi S. et al. Pioglitazone ameliorates high glucose induced desensitization of insulin receptor kinase in Rat 1 fibroblasts in culture. Biochem. Biophys. Res. Commun. 197:1993;1078-1082.
25. Maegawa H., Ide R., Hasegawa M. et al. Thiazolidine derivatives ameliorate high glucose-induced insulin resistance via the normalization of protein-tyrosine phosphatase activities. J. Biol. Chem. 270:1995;7724-7730.
26. Suter S.L., Nolan J.J., Wallace P., Gumbiner B., Olefsky J.M. Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects. Diabetes Care. 15:1992;193-203.